Core Scientific, Inc. (CORZ) Financial Statements
Industry: Finance Services
In fiscal 2025, Core Scientific reported revenue of $319.0M, down 37.5% from $510.7M the year before. Net income was -$288.6M (a -90.5% net margin), or -$0.88 per diluted share. Gross margin was 11.9% and operating margin was -77.0%. Operating activities generated $278.2M of cash, leaving -$450.8M of free cash flow. At fiscal year end, Core Scientific held $2.35B in total assets against $3.31B in total liabilities, including $311.4M of cash and equivalents.
Open the full interactive Core Scientific financials → Quarterly statements, key ratios, valuation history and price charts.
Core Scientific Key Stats
| Share Price | $15.43 |
|---|---|
| Market Cap | $5.02B |
| Revenue YoY Growth | -37.5% |
| 52-Week Range | $13.57 – $29.16 |
| Shares Outstanding | 325.3 million (basic, 2026 Q2) |
Core Scientific Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $640.3M | $502.4M | $510.7M | $319.0M |
| Gross Profit | — | $8.4M | $123.5M | $121.1M | $37.9M |
| Operating Income | -$5.2M | -$2.11B | $9.0M | -$19.2M | -$245.6M |
| Pre-Tax Income | -$32.5M | -$2.16B | -$245.8M | -$1.31B | -$288.0M |
| Income Tax | $0 | -$17.1M | $683,000 | $859,000 | $583,000 |
| Net Income | -$32.5M | -$2.15B | -$246.5M | -$1.32B | -$288.6M |
| Diluted EPS | -$1.06 | -$6.30 | -$0.65 | -$4.39 | -$0.88 |
Core Scientific Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $81.1M | $79.8M | $115.2M | $164.2M |
| Net Income | -$146.7M | $214.2M | -$347.2M | -$1.16B |
| Diluted EPS | -$0.46 | $0.67 | -$1.06 | -$3.32 |
Core Scientific Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $970,876 | $15.9M | $50.4M | $836.2M | $311.4M |
| Current Assets | $1.3M | $85.1M | $97.0M | $904.0M | $895.5M |
| Total Assets | $346.4M | $807.7M | $712.2M | $1.60B | $2.35B |
| Current Liabilities | $4.2M | $186.8M | $488.4M | $134.6M | $781.4M |
| Total Long-Term Debt | — | — | $808.4M | $1.09B | $1.06B |
| Total Liabilities | $65.6M | $1.22B | $1.31B | $2.42B | $3.31B |
| Shareholders' Equity | -$64.2M | -$409.3M | -$596.9M | -$820.2M | -$962.7M |
Core Scientific Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$1.9M | $205.2M | $65.1M | $42.9M | $278.2M |
| Cash From Investing | -$345.0M | -$590.8M | -$3.0M | -$95.2M | -$740.8M |
| Cash From Financing | $347.8M | $306.2M | -$44.6M | $819.6M | -$63.1M |
| Free Cash Flow | — | -$178.8M | $49.0M | -$52.1M | -$450.8M |
Figures from Core Scientific's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Core Scientific financials page for every line item.
Core Scientific Company Profile
| Ticker | CORZ |
|---|---|
| Exchange | Nasdaq, OTC |
| Industry | Finance Services |
| Headquarters | Dover, Delaware |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001839341 |
Frequently Asked Questions
What was Core Scientific's revenue in fiscal 2025?
Core Scientific (CORZ) reported revenue of $319.0M for fiscal 2025.
What is Core Scientific's annual revenue history?
Core Scientific's annual revenue by fiscal year: 2021: $0; 2022: $640.3M; 2023: $502.4M; 2024: $510.7M; 2025: $319.0M.
What was Core Scientific's net income in fiscal 2025?
Core Scientific reported net income of -$288.6M for fiscal 2025.
What was Core Scientific's earnings per share (EPS) in fiscal 2025?
Core Scientific's diluted EPS was -$0.88 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Core Scientific generate in fiscal 2025?
Core Scientific generated -$450.8M of free cash flow in fiscal 2025.
What was Core Scientific's revenue last quarter?
In its most recent reported quarter (2026 Q2), Core Scientific reported revenue of $164.2M.
How much debt does Core Scientific have?
Core Scientific reported $1.06B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Core Scientific are outstanding?
Core Scientific reported a weighted average of 325.3 million basic shares outstanding in 2026 Q2.
What is Core Scientific's market cap?
Based on its latest closing price, Core Scientific (CORZ) has a market capitalization of about $5.02B.
When does Core Scientific's fiscal year end?
Core Scientific's fiscal year end, as registered with the SEC, is December 31.
Where is Core Scientific headquartered?
Core Scientific lists its business address in Dover, Delaware in its SEC filings.